aMoon Fund

Roy Wiesner, Adv , MPA Chief Communications Officer & Head of IR Chief People Officer & Chief of Staff Chief Compliance Officer & CISO VP Business Development, aMoon Alpha Warburg Pincus Co-Leads Latest Funding Round in Israel's MDClone Andreessen, Founders Fund Back Genomics Startup Exiting Stealth Welcome to 'tissue therapeutics’: Dave Lennon’s $110M new venture will implant ‘happy cells’ that ‘survive and thrive’ Eleos Health raises $20 million to generate insights from mental health clinician-patient conversations Nectin Therapeutics Announces $5 4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy aMoon UN PRI Announcement Ushering in a New Era: The $100 Genome is Here When the Stars Align: The Story of our Investment in Sophia Genetics How AI interfaces can help therapists provide better behavioral healthcare The Omics Era Dawns for Tools and Diagnostics The Year HealthTech Grew Wings Are Devices the Next Gen Pharmaceuticals? We just made our largest investment to date in Seer Let us tell you why: Driving to Target: How Adicet Bio’s Novel Therapy Addresses Key Drawbacks in Immune-Oncology Healthcare is Going Vocal